Compare Medpace Holdings Inc (MEDP) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs PPG Industries, Inc. — how do they compare? Medpace Holdings Inc trades at $534.03 (market cap $15.08B), while PPG Industries, Inc. trades at $116.69 (market cap $25.79B). The key difference: PPG Industries, Inc. is the larger of the two by market cap, and PPG Industries, Inc. pays a 2.56% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PPG | |
|---|---|---|
Market Cap | $15.08B | $25.79B |
Sector | Technology | Basic Materials |
52-Week High | $620.59 | $131.56 |
52-Week Low | $308.88 | $94.34 |
Enterprise Value | $14.55B | $31.90B |
Dividend Yield | — | 2.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
PPG Industries trades at $115.67, down 1.44% on the day. The stock shows a bullish technical trend with strong moving averages, while fundamentals reflect solid profitability with a 9.83% net income margin and a P/E of 16.81. Recent news highlights a dividend increase to $0.74 per share and innovation in aerospace coatings, signaling management's confidence in cash flow growth.
The outlook is positive, supported by analyst consensus with a $132.20 price target and 55% buy ratings. Key opportunities include steady dividend growth and aerospace sector strength, while risks involve economic sensitivity and debt levels. Earnings on July 28 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
